N
VCYT icon

Nuveen’s Veracyte VCYT Stock Holding History

Nuveen’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.68M Sell
238,439
-343,835
-59% -$12.7M ﹤0.01% 1704
2025
Q4 		$24.5M Sell
582,274
-139,275
-19% -$5.61M 0.01% 1024
2025
Q3 		$24.8M Sell
721,549
-108,049
-13% -$3.1M 0.01% 1018
2025
Q2 		$22.4M Sell
829,598
-283,474
-25% -$8.21M 0.01% 1027
2025
Q1 		$33M Sell
1,113,072
-81,320
-7% -$3.1M 0.01% 821
2024
Q4 		$47.3M Buy
1,194,392
+8,797
+0.7% +$333K 0.01% 674
2024
Q3 		$40.4M Buy
1,185,595
+472,901
+66% +$13.3M 0.01% 763
2024
Q2 		$15.4M Sell
712,694
-314,733
-31% -$6.62M ﹤0.01% 1304
2024
Q1 		$22.8M Buy
1,027,427
+5,148
+0.5% +$126K 0.01% 1107
2023
Q4 		$28.1M Sell
1,022,279
-75,003
-7% -$1.81M 0.01% 928
2023
Q3 		$24.5M Buy
1,097,282
+165,505
+18% +$4.26M 0.01% 930
2023
Q2 		$23.7M Buy
931,777
+697
+0.1% +$16.9K 0.01% 972
2023
Q1 		$20.8M Buy
931,080
+651,413
+233% +$15.7M 0.01% 1023
2022
Q4 		$6.64M Buy
279,667
+14,971
+6% +$348K ﹤0.01% 1753
2022
Q3 		$4.39M Sell
264,696
-5,245
-2% -$118K ﹤0.01% 1977
2022
Q2 		$5.37M Buy
269,941
+1,047
+0.4% +$21.2K ﹤0.01% 1894
2022
Q1 		$7.32M Sell
268,894
-5,111
-2% -$146K ﹤0.01% 1839
2021
Q4 		$11M Sell
274,005
-206,343
-43% -$9.12M ﹤0.01% 1631
2021
Q3 		$24.6M Buy
480,348
+45,214
+10% +$1.97M 0.01% 1127
2021
Q2 		$17.4M Sell
435,134
-41,068
-9% -$1.76M 0.01% 1481
2021
Q1 		$25.6M Sell
476,202
-51,943
-10% -$2.99M 0.01% 1138
2020
Q4 		$25.8M Sell
528,145
-3,227
-0.6% -$150K 0.01% 1081
2020
Q3 		$17.3M Buy
531,372
+183,168
+53% +$5.82M 0.01% 1151
2020
Q2 		$9.02M Sell
348,204
-81,789
-19% -$2.04M ﹤0.01% 1546
2020
Q1 		$10.5M Sell
429,993
-121,412
-22% -$3.06M 0.01% 1263
2019
Q4 		$15.4M Sell
551,405
-572,661
-51% -$14.8M 0.01% 1325
2019
Q3 		$27M Sell
1,124,066
-51,131
-4% -$1.36M 0.01% 971
2019
Q2 		$33.5M Buy
+1,175,197
New +$29.4M 0.01% 882

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Nuveen's VCYT Position: Q1 2026 in Review

Nuveen reduced its Veracyte (VCYT) stake by 59% in Q1 2026, selling an estimated $12.7M and leaving 238,439 shares worth $7.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1704.

Nuveen first reported a position in VCYT in Q2 2019 and has held it in 28 quarters since. The position peaked at $47.3M in Q4 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Nuveen held 238,439 shares of Veracyte worth $7.68M as of Q1 2026.
  • Nuveen sold 343,835 Veracyte shares in Q1 2026, an estimated $12.7M.
  • Veracyte made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #1704 holding.
  • Nuveen first reported a position in Veracyte in Q2 2019 and has held it in 28 quarters since.
  • Nuveen's Veracyte position peaked at $47.3M in Q4 2024.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.